Caroline Hendry, PhD

Caroline is the Scientific Director and Advisor to the Chair of Genetics at Yale School of Medicine. She is also the Director of the Office for Strategic Research Development, responsible for increasing research innovation and discovery through strategic portfolio planning, advisory and collaboration. Caroline leads cross-functional capacity building activities in high growth areas including rare disease research, population/preventative health screening, and IND-enabling R&D for gene- and cell-based therapies. She plays a key role in enabling highly efficient operational processes/systems across basic and clinical research.

Caroline was born in Brisbane, Australia and earned her undergraduate degree in Genetics at the University of Queensland, Australia. She earned her PhD in developmental genetics under Prof Melissa Little at the Institute for Molecular Bioscience and her postdoc in molecular reprogramming under Prof Ihor Lemishka at the Mount Sinai School of Medicine, NY. Following her postdoc, Caroline moved to Cambridge, UK, where she took on a new role as Reviews Editor for the journal Development, covering the stem cells and regeneration fields.

Caroline was recruited to Yale in 2018 and is a co-Investigator on several large NIH grants in the clinical-translational space. In addition to her scientific training, she has extensive experience in project management, leadership and research administration. She is currently completing her MBA degree at the Yale School of Management, specializing in the healthcare sector.